BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33857636)

  • 1. Identification of hub molecules of FUS-ALS by Bayesian gene regulatory network analysis of iPSC model: iBRN.
    Nogami M; Ishikawa M; Doi A; Sano O; Sone T; Akiyama T; Aoki M; Nakanishi A; Ogi K; Yano M; Okano H
    Neurobiol Dis; 2021 Jul; 155():105364. PubMed ID: 33857636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons.
    Akiyama T; Suzuki N; Ishikawa M; Fujimori K; Sone T; Kawada J; Funayama R; Fujishima F; Mitsuzawa S; Ikeda K; Ono H; Shijo T; Osana S; Shirota M; Nakagawa T; Kitajima Y; Nishiyama A; Izumi R; Morimoto S; Okada Y; Kamei T; Nishida M; Nogami M; Kaneda S; Ikeuchi Y; Mitsuhashi H; Nakayama K; Fujii T; Warita H; Okano H; Aoki M
    EBioMedicine; 2019 Jul; 45():362-378. PubMed ID: 31262712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.
    Liu X; Chen J; Liu W; Li X; Chen Q; Liu T; Gao S; Deng M
    Neurogenetics; 2015 Jul; 16(3):223-31. PubMed ID: 25912081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of In Vitro FUS-Associated Familial Amyotrophic Lateral Sclerosis Model Using Human Induced Pluripotent Stem Cells.
    Ichiyanagi N; Fujimori K; Yano M; Ishihara-Fujisaki C; Sone T; Akiyama T; Okada Y; Akamatsu W; Matsumoto T; Ishikawa M; Nishimoto Y; Ishihara Y; Sakuma T; Yamamoto T; Tsuiji H; Suzuki N; Warita H; Aoki M; Okano H
    Stem Cell Reports; 2016 Apr; 6(4):496-510. PubMed ID: 26997647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging.
    Japtok J; Lojewski X; Naumann M; Klingenstein M; Reinhardt P; Sterneckert J; Putz S; Demestre M; Boeckers TM; Ludolph AC; Liebau S; Storch A; Hermann A
    Neurobiol Dis; 2015 Oct; 82():420-429. PubMed ID: 26253605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation.
    Naumann M; Pal A; Goswami A; Lojewski X; Japtok J; Vehlow A; Naujock M; Günther R; Jin M; Stanslowsky N; Reinhardt P; Sterneckert J; Frickenhaus M; Pan-Montojo F; Storkebaum E; Poser I; Freischmidt A; Weishaupt JH; Holzmann K; Troost D; Ludolph AC; Boeckers TM; Liebau S; Petri S; Cordes N; Hyman AA; Wegner F; Grill SW; Weis J; Storch A; Hermann A
    Nat Commun; 2018 Jan; 9(1):335. PubMed ID: 29362359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Regulatory Circuitry Between Gria2, miR-409, and miR-495 Is Affected by ALS FUS Mutation in ESC-Derived Motor Neurons.
    Capauto D; Colantoni A; Lu L; Santini T; Peruzzi G; Biscarini S; Morlando M; Shneider NA; Caffarelli E; Laneve P; Bozzoni I
    Mol Neurobiol; 2018 Oct; 55(10):7635-7651. PubMed ID: 29430619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations.
    Bursch F; Kalmbach N; Naujock M; Staege S; Eggenschwiler R; Abo-Rady M; Japtok J; Guo W; Hensel N; Reinhardt P; Boeckers TM; Cantz T; Sterneckert J; Van Den Bosch L; Hermann A; Petri S; Wegner F
    Hum Mol Genet; 2019 Sep; 28(17):2835-2850. PubMed ID: 31108504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of β-catenin due to loss of miR-139 contributes to motor neuron death in amyotrophic lateral sclerosis.
    Hawkins S; Namboori SC; Tariq A; Blaker C; Flaxman C; Dey NS; Henley P; Randall A; Rosa A; Stanton LW; Bhinge A
    Stem Cell Reports; 2022 Jul; 17(7):1650-1665. PubMed ID: 35750046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis.
    Wang H; Guo W; Mitra J; Hegde PM; Vandoorne T; Eckelmann BJ; Mitra S; Tomkinson AE; Van Den Bosch L; Hegde ML
    Nat Commun; 2018 Sep; 9(1):3683. PubMed ID: 30206235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FUS Mutant Human Motoneurons Display Altered Transcriptome and microRNA Pathways with Implications for ALS Pathogenesis.
    De Santis R; Santini L; Colantoni A; Peruzzi G; de Turris V; Alfano V; Bozzoni I; Rosa A
    Stem Cell Reports; 2017 Nov; 9(5):1450-1462. PubMed ID: 28988989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isogenic FUS-eGFP iPSC Reporter Lines Enable Quantification of FUS Stress Granule Pathology that Is Rescued by Drugs Inducing Autophagy.
    Marrone L; Poser I; Casci I; Japtok J; Reinhardt P; Janosch A; Andree C; Lee HO; Moebius C; Koerner E; Reinhardt L; Cicardi ME; Hackmann K; Klink B; Poletti A; Alberti S; Bickle M; Hermann A; Pandey UB; Hyman AA; Sterneckert JL
    Stem Cell Reports; 2018 Feb; 10(2):375-389. PubMed ID: 29358088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons.
    Lenzi J; De Santis R; de Turris V; Morlando M; Laneve P; Calvo A; Caliendo V; Chiò A; Rosa A; Bozzoni I
    Dis Model Mech; 2015 Jul; 8(7):755-66. PubMed ID: 26035390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis.
    Lim SM; Choi WJ; Oh KW; Xue Y; Choi JY; Kim SH; Nahm M; Kim YE; Lee J; Noh MY; Lee S; Hwang S; Ki CS; Fu XD; Kim SH
    Mol Neurodegener; 2016 Jan; 11():8. PubMed ID: 26795035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA Sequencing Reveals Neurodegeneration-Associated FUS Mutations Alter Transcriptional Landscape of iPS Cells That Persists in Motor Neurons.
    Provasek VE; Kodavati M; Guo W; Wang H; Boldogh I; Van Den Bosch L; Britz G; Hegde ML
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FUS ALS neurons activate major stress pathways and reduce translation as an early protective mechanism against neurodegeneration.
    Szewczyk B; Günther R; Japtok J; Frech MJ; Naumann M; Lee HO; Hermann A
    Cell Rep; 2023 Feb; 42(2):112025. PubMed ID: 36696267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of an induced pluripotent stem cell line (UCSCi001-A) from a patient with early-onset amyotrophic lateral sclerosis carrying a FUS variant.
    Martello F; Lattante S; Doronzio PN; Conte A; Bisogni G; Orteschi D; Pirozzi F; Sabatelli M; Zollino M; Marangi G
    Stem Cell Res; 2021 Aug; 55():102461. PubMed ID: 34303285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of six induced pluripotent stem cell lines from patients with amyotrophic lateral sclerosis with associated genetic mutations in either FUS or ANXA11.
    Hedges EC; Topp S; Shaw CE; Nishimura AL
    Stem Cell Res; 2021 Apr; 52():102246. PubMed ID: 33610019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons.
    Wang WY; Pan L; Su SC; Quinn EJ; Sasaki M; Jimenez JC; Mackenzie IR; Huang EJ; Tsai LH
    Nat Neurosci; 2013 Oct; 16(10):1383-91. PubMed ID: 24036913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients.
    Guo W; Naujock M; Fumagalli L; Vandoorne T; Baatsen P; Boon R; Ordovás L; Patel A; Welters M; Vanwelden T; Geens N; Tricot T; Benoy V; Steyaert J; Lefebvre-Omar C; Boesmans W; Jarpe M; Sterneckert J; Wegner F; Petri S; Bohl D; Vanden Berghe P; Robberecht W; Van Damme P; Verfaillie C; Van Den Bosch L
    Nat Commun; 2017 Oct; 8(1):861. PubMed ID: 29021520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.